Eli Lilly is considering offering more Zepbound doses in vials at lower cost
Eli Lilly’s CEO says the company is considering offering more Zepbound doses in vials at lower cost.
Eli Lilly’s CEO says the company is considering offering more Zepbound doses in vials at lower cost.
Guest Co-Editors: Regina Wright, PhD, FGSA (University of Delaware, USA) and Samuele Zilioli, PhD (Wayne State University, USA).
You may have to wait to re-download the app.
In this video, you’ll see an interview with President and CEO of Protean BioDiagnostics, Tony Magliocco, and Precision Cancer Medicine Patient Educator and A…
A novel strategy of preemptive facial nerve rewiring for a teenager with a facial nerve tumor enabled eventual tumor resection without facial paralysis.
Trump claims there’s ‘no risk’ to the US.
There are only a few ways to ensure their protection.
A Minnesota-based glazing firm is using a robotic system to install high-rise glass panel bracket. Harmon is installing the latest technology with the help of…
“The FAIR Plan, a not-for-profit catastrophe insurer, has the payment mechanisms in place to ensure all covered claims will be paid.”
Highly contagious noroviruses cause miserable symptoms, and infections have been on the uptick in recent weeks.
A record number of individuals had their data stolen in 2024, but the healthcare industry may be more committed than ever to addressing the threat.